Leukemia Stem Cell Drug Discovery.
Cobaleda C, Sánchez-García I,
Methods Mol Biol;2021;2185();39-48;33165841

Leukemia Stem Cells: Concept and Implications.
Sánchez-García I, Cobaleda C,
Methods Mol Biol;2021;2185();25-37;33165840

The role of mA, mC and Ψ RNA modifications in cancer: Novel therapeutic opportunities.
Nombela P, Miguel-López B, Blanco S,
Mol Cancer;2021;20(1);18;33461542

Novel Dominant KCNQ2 Exon 7 Partial In-Frame Duplication in a Complex Epileptic and Neurodevelopmental Delay Syndrome.
Lazo PA, García JL, Gómez-Puertas P, Marcos-Alcalde I, Arjona C, Villarroel A, González-Sarmiento R, Fons C,
Int J Mol Sci;2020;21(12);E4447;32585800

Identification of distinct maturation steps involved in human 40S ribosomal subunit biosynthesis.
Nieto B, Gaspar SG, Moriggi G, Pestov DG, Bustelo XR, Dosil M,
Nat Commun;2020;11(1);156;31919354

Securin-independent regulation of separase by checkpoint-induced shugoshin-MAD2.
Hellmuth S, Gomez-H L, Pendas AM, Stemmann O,
Nature;2020;580(7804);536-541;32322060

Emerging roles of novel small non-coding regulatory RNAs in immunity and cancer.
Rosace D, López J, Blanco S,
RNA Biol;2020;17(8);1196-121;32186461

VRK1 (Y213H) homozygous mutant impairs Cajal bodies in a hereditary case of distal motor neuropathy.
Marcos AT, Martín-Doncel E, Morejón-García P, Marcos-Alcalde I, Gómez-Puertas P, Segura-Puimedon M, Armengol L, Navarro-Pando JM, Lazo PA,
Ann Clin Transl Neurol;2020;7(5);808-818;32365420

Working on Genomic Stability: From the S-Phase to Mitosis.
Ovejero S, Bueno A, Sacristán MP,
Genes (Basel);2020;11(2);E225;32093406

C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation.
Sequera C, Bragado P, Manzano S, Arechederra M, Richelme S, Gutierrez-Uzquiza A, Sánchez A, Maina F, Guerrero C, Porras A,
Cancers (Basel);2020;12(8);E2282;32823931

C3G contributes to platelet activation and aggregation by regulating major signaling pathways.
Gutiérrez-Herrero S, Fernández-Infante C, Hernández-Cano L, Ortiz-Rivero S, Guijas C, Martín-Granado V, González-Porras JR, Balsinde J, Porras A, Guerrero C,
Signal Transduct Target T;2020;5(1);29;32296045

Mechanisms of autoregulation of C3G, activator of the GTPase Rap1, and its catalytic deregulation in lymphomas.
Carabias A, Gómez-Hernández M, de Cima S, Rodríguez-Blázquez A, Morán-Vaquero A, González-Sáenz P, Guerrero C, de Pereda JM,
Sci Signal;2020;13(647);eabb7075;32873726

Drug Vulnerabilities and Disease Prognosis Linked to the Stem Cell-Like Gene Expression Program Triggered by the RHO GTPase Activator VAV2 in Hyperpla
Lorenzo-Martín LF, Menacho-Márquez M, Bustelo XR,
Cancers (Basel);2020;12(9);E2498;32899210

HERC Ubiquitin Ligases in Cancer.
Sala-Gaston J, Martinez-Martinez A, Pedrazza L, Lorenzo-Martín LF, Caloto R, Bustelo XR, Ventura F, Rosa JL,
Cancers (Basel);2020;12(6);E1653;32580485

Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor.
Lorenzo-Martín LF, Rodríguez-Fdez S, Fabbiano S, Abad A, Garcia-Macias MC, Dosil M, Cuadrado M, Robles-Valero J, Bustelo XR,
Oncogene;2020;39(28);5098-511;32528129